Turmeric and breast cancer.

Turmeric and Curcumin has natural anti cancer activity.Research has also shown that there are low rates of certain types of cancer in countries where people eat curcumin at levels of about 100 to 200 mg a day over long periods of time. Research have shown curcumin combats cancers of the breast, prostate, liver, colon, lung, pancreas and more. Many of these studies have shown that curcumin actually stops cancer cells from dividing. Curcumin has also been shown to trigger programmed cell death the body’s natural and effective way of ridding itself from damaged cells. A recent study published in Cancer Cell International, 2017 demonstrated that curcumin and its derivatives can terminate breast cancer cells by arresting their development in various phases of cell cycle and growth and inducing cell death. A new study shows that curcumin may be beneficial in treatment of non-malignant or benign breast tumors as well as a study published in Anticancer Research 2005, demonstrates that curcumin regulates as many as 30 genes and acts on multiple biochemical pathways in order to destroy breast cancer cells. Researchers in France have conducted a clinical trial to identify the dose suitable for advanced or metastatic breast cancer treatment. As per the study the recommended dose of curcumin is 6000mg per day for 7 consecutive days every 3 weeks along with standard docetaxel treatment. Turmeric and Curcumin also acts as topical agents in cancer therapy, study involved patients who had external cancerous lesions and some of them were breast cancer lesions. These lesions did not respond to treatment. Turmeric tincture was mixed with petroleum jelly and patients were asked to apply this preparation thrice a day on the external lesions. 90% individuals experienced a reduction in smell, itching reduced in almost all cases while 70% individuals experienced drying up of lesions and 10% of patients experienced reduction in lesion size and pain.